MCID: RDT005
MIFTS: 27

Radiation Induced Cancer

Categories: Rare diseases, Cancer diseases

Aliases & Classifications for Radiation Induced Cancer

MalaCards integrated aliases for Radiation Induced Cancer:

Name: Radiation Induced Cancer 50
Radiation-Induced Cancer 52 69
Radiation Related Cancer 50

Classifications:



Summaries for Radiation Induced Cancer

MalaCards based summary : Radiation Induced Cancer, also known as radiation-induced cancer, is related to thyroiditis and cystic fibrosis. An important gene associated with Radiation Induced Cancer is BRCA1 (BRCA1, DNA Repair Associated). The drugs Sucralfate and Acetylcysteine have been mentioned in the context of this disorder. Affiliated tissues include lung, brain and skin.

Wikipedia : 72 Up to 10% of invasive cancers are related to radiation exposure, including both ionizing radiation and... more...

Related Diseases for Radiation Induced Cancer

Diseases related to Radiation Induced Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 16)
id Related Disease Score Top Affiliating Genes
1 thyroiditis 9.7
2 cystic fibrosis 9.5
3 medulloblastoma 9.5
4 crohn's disease 9.5
5 lymphoma 9.5
6 sarcoma 9.5
7 prostatitis 9.5
8 squamous cell carcinoma 9.5
9 thyroid cancer 9.5
10 pigmented villonodular synovitis 9.5
11 synovitis 9.5
12 cockayne syndrome 9.5
13 testicular cancer 9.5
14 childhood medulloblastoma 9.5
15 appendicitis 9.5
16 villonodular synovitis 9.5

Graphical network of the top 20 diseases related to Radiation Induced Cancer:



Diseases related to Radiation Induced Cancer

Symptoms & Phenotypes for Radiation Induced Cancer

Drugs & Therapeutics for Radiation Induced Cancer

Drugs for Radiation Induced Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 515)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sucralfate Approved Phase 4,Phase 3 54182-58-0
2
Acetylcysteine Approved, Investigational Phase 4,Phase 2 616-91-1 12035
3
Cisplatin Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 15663-27-1 84093 441203 2767
4
Amifostine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 20537-88-6 2141
5
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 33069-62-4 36314
6
Cevimeline Approved Phase 4 107233-08-9 83898 25137844
7
Bicalutamide Approved Phase 4,Phase 3 90357-06-5 56069 2375
8 Antacids Phase 4,Phase 3,Phase 2
9 Anti-Ulcer Agents Phase 4,Phase 3,Phase 2
10 Gastrointestinal Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
11 Antidotes Phase 4,Phase 3,Phase 2
12 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
13 Antioxidants Phase 4,Phase 3,Phase 2,Phase 1
14 Antiviral Agents Phase 4,Phase 2,Phase 3,Phase 1
15 Expectorants Phase 4,Phase 2
16 N-monoacetylcystine Phase 4,Phase 2
17 Protective Agents Phase 4,Phase 3,Phase 2,Phase 1
18 Respiratory System Agents Phase 4,Phase 3,Phase 2
19 Radiation-Protective Agents Phase 4,Phase 3,Phase 2,Phase 1
20 Autonomic Agents Phase 4,Phase 3,Phase 2,Phase 1
21 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
22 Androgen Antagonists Phase 4,Phase 3
23 Androgens Phase 4,Phase 3,Phase 2,Phase 1
24 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
25 Hormones Phase 4,Phase 3,Phase 2,Phase 1
26 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
27 Albumin-Bound Paclitaxel Phase 4,Phase 3,Phase 2,Phase 1
28 Antimitotic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
29 Antineoplastic Agents, Phytogenic Phase 4,Phase 2,Phase 3,Phase 1
30 Cholinergic Agents Phase 4,Phase 2,Phase 3
31 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1
32 Acidophilus Nutraceutical Phase 4,Phase 3
33
Cyproterone Acetate Approved, Investigational Phase 3 427-51-0
34
Capecitabine Approved, Investigational Phase 2, Phase 3, Phase 1 154361-50-9 60953
35
Fluorouracil Approved Phase 2, Phase 3, Phase 1, Early Phase 1 51-21-8 3385
36
Irinotecan Approved, Investigational Phase 2, Phase 3, Phase 1 97682-44-5, 100286-90-6 60838
37
Oxaliplatin Approved, Investigational Phase 2, Phase 3, Phase 1 61825-94-3 5310940 9887054 43805 6857599
38
Pancrelipase Approved Phase 2, Phase 3, Phase 1, Early Phase 1 53608-75-6
39
Etoposide Approved Phase 2, Phase 3, Phase 1 33419-42-0 36462
40
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
41
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
42
Hydroxyurea Approved Phase 3,Phase 2,Phase 1 127-07-1 3657
43
Busulfan Approved, Investigational Phase 3,Phase 1,Phase 2 55-98-1 2478
44
Dactinomycin Approved Phase 3,Phase 2 50-76-0 2019 457193
45
Ifosfamide Approved Phase 3,Phase 2 3778-73-2 3690
46
Mechlorethamine Approved Phase 3,Phase 2,Phase 1 51-75-2 4033
47
Melphalan Approved Phase 3,Phase 2,Phase 1 148-82-3 4053 460612
48
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
49
Carboplatin Approved Phase 3,Phase 2,Phase 1,Early Phase 1 41575-94-4 10339178 498142 38904
50
Lenograstim Approved Phase 3,Phase 2,Phase 1 135968-09-1

Interventional clinical trials:

(show top 50) (show all 857)

id Name Status NCT ID Phase Drugs
1 ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial Unknown status NCT02016807 Phase 4
2 THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS Unknown status NCT02241876 Phase 4 N-acetylcysteine
3 Subcutaneous Amifostine Safety Study Completed NCT00158041 Phase 4 Amifostine administered subcutaneously
4 Study of the Effectiveness of Cevimeline on Oral Health in Patients With Radiation Induced Xerostomia Completed NCT00466388 Phase 4 Cevimeline
5 Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX Completed NCT00590213 Phase 4 Casodex 150mg
6 Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC) Completed NCT00686322 Phase 4 Concurrent chemoradiotherapy (paclitaxel plus cisplatin plus radiotherapy)
7 Effectiveness of Low Energy Laser Treatment in Oral Mucositis Induced by Chemotherapy and Radiotherapy in Head and Neck Cancer Recruiting NCT01876407 Phase 4
8 Effect of Lactobacillus Brevis CD2 in Prevention of Radio-chemotherapy Induced Oral Mucositis in Head and Neck Cancer Recruiting NCT01707641 Phase 4
9 Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia Unknown status NCT00081029 Phase 3
10 Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer Unknown status NCT00392535 Phase 3 cyproterone acetate;releasing hormone agonist therapy
11 Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas Unknown status NCT02311439 Phase 2, Phase 3 FOLFIRINOX + CRT
12 A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer Unknown status NCT01731548 Phase 2, Phase 3
13 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer Unknown status NCT00002858 Phase 3 cisplatin;cyclophosphamide;doxorubicin hydrochloride;etoposide
14 Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) Unknown status NCT00117572 Phase 3 docetaxel;cisplatin;hydroxyurea;fluorouracil
15 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Unknown status NCT00020566 Phase 3 busulfan;doxorubicin hydrochloride;etoposide;ifosfamide;melphalan;vincristine sulfate
16 Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors Unknown status NCT00392886 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide;methotrexate;temozolomide;thiotepa;vincristine sulfate
17 COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma Unknown status NCT00603759 Phase 3 celecoxib;placebo
18 Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC Unknown status NCT01854203 Phase 2, Phase 3 Inductive chemotherapy + concurrent cisplatin and IMRT;Inductive chemotherapy + IMRT
19 A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma Unknown status NCT02444949 Phase 3 endostar;cisplatin
20 Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2 Unknown status NCT00273494 Phase 3
21 Magic Mouthwash Plus Sucralfate Versus Benzydamine Hydrochloride for the Treatment of Radiation-induced Mucositis Completed NCT00814359 Phase 3 Combination of Magic Mouthwash Plus Sucralfate;0.15% Benzydamine HCl
22 CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy Completed NCT00122772 Phase 3
23 Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer Completed NCT00656513 Phase 2, Phase 3 Pilocarpine
24 Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer Completed NCT00006481 Phase 3 Biafine cream
25 Trial Comparing Best Supportive Care to Aloe Vera Gel Completed NCT00876642 Phase 3 Aloe vera gel
26 Oral Curcumin for Radiation Dermatitis Completed NCT01246973 Phase 2, Phase 3 Curcumin;Placebo
27 Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy Completed NCT00003610 Phase 3
28 Ondansetron With or Without Dexamethasone to Prevent Vomiting in Patients Receiving Radiation Therapy to the Upper Abdomen Completed NCT00016380 Phase 3 dexamethasone;ondansetron
29 Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting From Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, or Nasopharynx Completed NCT00051441 Phase 3 Benzydamine Hydrochloride 0.15% Oral Rinse
30 Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone Metastases Completed NCT01248585 Phase 3 Dexamethasone;Placebo
31 Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation Completed NCT01839721 Phase 3 Bifilact®
32 Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients Completed NCT00168181 Phase 3 Salagen
33 Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation Completed NCT01762020 Phase 3 Standard Preparation
34 Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting Completed NCT00971399 Phase 3 ramosetron;ondansetron
35 Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery Completed NCT00003387 Phase 3 carboplatin;chemotherapy;paclitaxel
36 A Randomized Placebo-Controlled Trial of Manuka Honey for Oral Mucositis Due to Radiation Therapy for Cancer Completed NCT00615420 Phase 3
37 Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer Completed NCT00003313 Phase 3 amifostine trihydrate;carboplatin;paclitaxel
38 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed Completed NCT00003235 Phase 3 carboplatin;paclitaxel
39 The Use of Silver Leaf Dressing in the Prevention of Radiotherapy Induced Skin Reactions Completed NCT00207324 Phase 3
40 Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer Completed NCT00253591 Phase 2, Phase 3 cisplatin;vinorelbine tartrate
41 A Clinical Trial to Reduce Skin Burn Induced by Breast Radiotherapy Using Intensity Modulated Radiation Therapy (IMRT) Completed NCT00187343 Phase 3
42 Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx Completed NCT00002496 Phase 3 chemotherapy;cisplatin;fluorouracil
43 Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer Completed NCT00002623 Phase 3 carboplatin;cisplatin
44 Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx Completed NCT00002839 Phase 3 cisplatin;fluorouracil
45 Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer Completed NCT00075868 Phase 3 octreotide acetate
46 Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer Completed NCT00057876 Phase 3 Gemcitabine
47 Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer Completed NCT00002550 Phase 3 cisplatin;etoposide
48 Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor Completed NCT00006461 Phase 3 cisplatin;cyclophosphamide;vincristine sulfate;etoposide
49 TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma Completed NCT01542931 Phase 2, Phase 3 TPF induction chemotherapy
50 Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery Completed NCT00020709 Phase 3 cisplatin;docetaxel;etoposide;gefitinib

Search NIH Clinical Center for Radiation Induced Cancer

Genetic Tests for Radiation Induced Cancer

Anatomical Context for Radiation Induced Cancer

MalaCards organs/tissues related to Radiation Induced Cancer:

39
Lung, Brain, Skin, Prostate, Liver, Bone, Breast

Publications for Radiation Induced Cancer

Articles related to Radiation Induced Cancer:

(show top 50) (show all 98)
id Title Authors Year
1
A novel mouse model of radiation-induced cancer survivorship diseases of the gut. ( 28729245 )
2017
2
Comparative study of the calculated risk of radiation-induced cancer after photon- and proton-beam based radiosurgery of liver metastases. ( 28366554 )
2017
3
Radiation-induced cancer risk predictions in proton and heavy ion radiotherapy. ( 28511776 )
2017
4
Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice. ( 28900036 )
2017
5
Organ-specific radiation-induced cancer risk estimates due to radiotherapy for benign pigmented villonodular synovitis. ( 27499236 )
2016
6
Non-targeted effects and radiation-induced cancer. ( 27893435 )
2016
7
Epidemiological research on radiation-induced cancer in atomic bomb survivors. ( 26976124 )
2016
8
An extra copy of p53 suppresses development of spontaneous Kras-driven but not radiation-induced cancer. ( 27453951 )
2016
9
Mass Spectrometry-Based Metabolomics Identifies Longitudinal Urinary Metabolite Profiles Predictive of Radiation-Induced Cancer. ( 26880804 )
2016
10
Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation. ( 26462717 )
2015
11
Communicating Potential Radiation-Induced Cancer Risks From Medical Imaging Directly to Patients. ( 26295534 )
2015
12
Concerning ionizing radiation-induced cancer from internally deposited radionuclides. ( 26063349 )
2015
13
ON THE ESTIMATION OF RADIATION-INDUCED CANCER RISKS FROM VERY LOW DOSES OF RADIATION AND HOW TO COMMUNICATE THESE RISKS. ( 25802468 )
2015
14
Assessment of uncertainties in radiation-induced cancer risk predictions at clinically relevant doses. ( 25563249 )
2015
15
Do we Really Need a Program to Compensate Aviation Crewmembers for Radiation-Induced Cancer? ( 25905523 )
2015
16
Adjustment of lifetime risks of space radiation-induced cancer by the healthy worker effect and cancer misclassification. ( 27441231 )
2015
17
Don't let radiation scare trump patient care: 10 ways you can harm your patients by fear of radiation-induced cancer from diagnostic imaging. ( 24764114 )
2014
18
Imaging for Appendicitis: Should Radiation-induced Cancer Risks Affect Modality Selection? ( 24988435 )
2014
19
Cancer risk from low dose radiation depends directly on the organ mass in a general model of radiation-induced cancer risk. ( 24562066 )
2014
20
Estimated risk of radiation-induced cancer following paediatric cranio-spinal irradiation with electron, photon and proton therapy. ( 25017376 )
2014
21
Curbing potential radiation-induced cancer risks in oncologic imaging: perspectives from the 'image gently' and 'image wisely' campaigns. ( 24855732 )
2014
22
In vivo radioadaptive response: A review of studies relevant to radiation-induced cancer risk. ( 24925363 )
2014
23
Estimated risk of radiation-induced cancer from paediatric chest CT: two-year cohort study. ( 25274469 )
2014
24
Patients with testicular cancer undergoing CT surveillance demonstrate a pitfall of radiation-induced cancer risk estimates: the timing paradox. ( 23249573 )
2013
25
Body CT scanning in young adults: examination indications, patient outcomes, and risk of radiation-induced cancer. ( 23386731 )
2013
26
How is the risk of radiation-induced cancer influenced by background risk factors? Invited commentary on "a method for determining weights for excess relative risk and excess absolute risk when applied in the calculation of lifetime risk of cancer from radiation exposure" by Walsh and Schneider (2012). ( 23180111 )
2013
27
Radiation-induced cancer: a modern view. ( 23175483 )
2012
28
Cost-effectiveness of imaging strategies to reduce radiation-induced cancer risk in Crohn's disease. ( 21928375 )
2012
29
Latency period of radiation-induced cancer. ( 22106106 )
2011
30
Meta-analysis of non-tumour doses for radiation-induced cancer on the basis of dose-rate. ( 21250929 )
2011
31
Neoplastic transformation in vitro: is it a valid assay or not for assessing the shape of the dose-response curve for radiation-induced cancer in vivo? ( 21595075 )
2011
32
Frequent body CT scanning of young adults: indications, outcomes, and risk for radiation-induced cancer. ( 21723488 )
2011
33
Radiation induced cancer arises from a somatic mutation. ( 21346281 )
2011
34
Radiation-induced cancer cell repopulation: a possible mechanism implied by experiments using transplantable mouse-derived sarcoma cell line. ( 21206131 )
2011
35
A new view of radiation-induced cancer. ( 21113062 )
2011
36
Scientific approach to radiation-induced cancer risk. ( 22353659 )
2011
37
Epidemiology of radiation-induced cancer. ( 21285730 )
2011
38
Comparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breast. ( 21302775 )
2010
39
A new view of radiation-induced cancer: integrating short- and long-term processes. Part I: approach. ( 19536557 )
2009
40
A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation. ( 19499238 )
2009
41
Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. ( 19332852 )
2009
42
Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula. ( 19472619 )
2009
43
Extrapolating radiation-induced cancer risks from low doses to very low doses. ( 19820460 )
2009
44
Radiation-induced cancer after radiotherapy for non-Hodgkin's lymphoma of the head and neck: a retrospective study. ( 19591686 )
2009
45
Systems biological and mechanistic modelling of radiation-induced cancer. ( 18097677 )
2008
46
Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. ( 18927099 )
2008
47
Monte Carlo determination of radiation-induced cancer risks for prostate patients undergoing intensity- modulated radiation therapy. ( 18449157 )
2007
48
Radiation-induced cancer risk from annual computed tomography for patients with cystic fibrosis. ( 17717201 )
2007
49
The issue of risk in complex adaptive systems: the case of low-dose radiation induced cancer. ( 16459709 )
2006
50
Understanding estimation of time and age effect-modification of radiation-induced cancer risks among atomic-bomb survivors. ( 17099404 )
2006

Variations for Radiation Induced Cancer

Expression for Radiation Induced Cancer

Search GEO for disease gene expression data for Radiation Induced Cancer.

Pathways for Radiation Induced Cancer

GO Terms for Radiation Induced Cancer

Sources for Radiation Induced Cancer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....